Delivery Order SPE2DB24D2003-SPE2DB24FXFM4
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product ORILISSA 150 MG TABLET 7S. The contract has a potential value of $2,115.75 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside designation. This award is part of Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication ORILISSA 150 MG TABLET 7S. The contract has a ceiling value of $8,814.15 and an ultimate completion date of June 13, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with a firm fixed price and a ceiling value of $1,504.04. The contract has an ultimate completion date of May 19, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB23FU13P) under an Indefinite Delivery Contract (SPE2DB20D2104) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Orilissa 200 mg tablets, a pharmaceutical product used for various medical treatments. The total ceiling value of this specific delivery order is $2,910.29, with a firm fixed price pricing type. The contract does not have a set-aside designation,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orilissa 150 mg tablets. The $11,137.57 contract has a completion date of May 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORILISSA 150 MG TABLET 7S, a medication, with a ceiling value of $12,606.64 and a performance period through June 6, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,131.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. This contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, is the prime contractor for this award. The company holds a significant Indefinite Delivery Contract (IDC)...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical for $2,845.34. As the prime contractor, Amerisourcebergen will supply 4563063585 ORILISSA 150 MG TABLET 7S to the DLA for delivery by December 12, 2023. The contract was awarded without a set-aside designation on December 11, 2023. Performance will take place at Amerisourcebergen's corporate headquarters in...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $5,402.40 firm fixed price contract is for the supply of the prescription medication Orilissa 150 mg tablets, with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...